We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+7.67%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$441M
AUM Growth
+$91.2M
Cap. Flow
+$74.5M
Cap. Flow %
16.9%
Top 10 Hldgs %
24.04%
Holding
1,099
New
222
Increased
266
Reduced
262
Closed
55

Top Buys

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$15.4M
2
STLA icon
Stellantis
STLA
+$9.9M
3
ALC icon
Alcon
ALC
+$7.77M
4
AMZN icon
Amazon
AMZN
+$6.64M
5
RACE icon
Ferrari
RACE
+$5.26M

Top Sells

Rank Stock Value
1
EWT icon
iShares MSCI Taiwan ETF
EWT
+$8.02M
2
RSX
VanEck Russia ETF
RSX
+$6.88M
3
LIN icon
Linde
LIN
+$5.74M
4
KSA icon
iShares MSCI Saudi Arabia ETF
KSA
+$5.13M
5
TUR icon
iShares MSCI Turkey ETF
TUR
+$4.56M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.26%
2 Technology 13.6%
3 Financials 12.86%
4 Healthcare 10.91%
5 Industrials 10.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EWJ icon
826
iShares MSCI Japan ETF
EWJ
$21.7B
$1.78K ﹤0.01%
26
– –
CC icon
827
Chemours
CC
$2.55B
$1.76K ﹤0.01%
52
– –
CSGP icon
828
CoStar Group
CSGP
$11.8B
$1.71K ﹤0.01%
20
-30
-60% -$2.59K
CAH icon
829
Cardinal Health
CAH
$53.6B
$1.66K ﹤0.01%
29
– –
VRNT
830
DELISTED
Verint Systems
VRNT
$1.61K ﹤0.01%
38
+27
+245% +$1.25K
CMG icon
831
Chipotle Mexican Grill
CMG
$42.3B
$1.61K ﹤0.01%
50
– –
DINO icon
832
HF Sinclair
DINO
$15.9B
$1.59K ﹤0.01%
51
– –
AKBA icon
833
Akebia Therapeutics
AKBA
$338M
$1.57K ﹤0.01%
471
– –
MTN icon
834
Vail Resorts
MTN
$5.4B
$1.56K ﹤0.01%
5
– –
HL icon
835
Hecla Mining
HL
$10B
$1.56K ﹤0.01%
221
– –
PFPT
836
DELISTED
Proofpoint, Inc.
PFPT
$1.56K ﹤0.01%
9
– –
XLRN
837
DELISTED
Acceleron Pharma
XLRN
$1.51K ﹤0.01%
13
– –
HES
838
DELISTED
Hess
HES
$1.51K ﹤0.01%
18
– –
PPL
839
PPL Corp
PPL
$27.2B
$1.51K ﹤0.01%
54
-563
-91% -$16.3K
CNC icon
840
Centene
CNC
$31.3B
$1.49K ﹤0.01%
20
– –
OUT icon
841
Outfront Media
OUT
$5.66B
$1.49K ﹤0.01%
63
– –
HR
842
DELISTED
Healthcare Realty Trust Incorporated
HR
$1.43K ﹤0.01%
47
-4,517
-99% -$141K
REZI icon
843
Resideo Technologies
REZI
$5.22B
$1.42K ﹤0.01%
50
– –
CPT icon
844
Camden Property Trust
CPT
$11.3B
$1.41K ﹤0.01%
10
– –
ALK icon
845
Alaska Air
ALK
$5.28B
$1.38K ﹤0.01%
+24
New +$1.62K
VIPS icon
846
Vipshop
VIPS
$6.97B
$1.37K ﹤0.01%
70
– –
CGAU
847
Centerra Gold
CGAU
$3.24B
$1.37K ﹤0.01%
+186
New +$1.55K
XME icon
848
State Street SPDR S&P Metals & Mining ETF
XME
$3.93B
$1.32K ﹤0.01%
31
-3,069
-99% -$133K
BURL icon
849
Burlington
BURL
$22.4B
$1.32K ﹤0.01%
4
– –
CLR
850
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$1.3K ﹤0.01%
34
– –
32 33
34
35 36

Similar funds

PC
Plaisance Capital Denver, Colorado $172M AUM 27.11% 1-Year Est. Return
TWMP
Taylor Wealth Management Partners Boston, Massachusetts $176M AUM 14.65% 1-Year Est. Return
LPWM
Lake Point Wealth Management Rockwall, Texas $176M AUM 11.87% 1-Year Est. Return
ACM
Aquamarine Capital Management New York $170M AUM 15.49% 1-Year Est. Return
HWIS
Hancock Whitney Investment Services New Orleans, Louisiana $157M AUM
LWM
Loveless Wealth Management Billings, Montana $153M AUM 3.63% 1-Year Est. Return
EW
Emerson Wealth Bloomfield Hills, Michigan $153M AUM 16.38% 1-Year Est. Return
GDWAM
Gold Dragon Worldwide Asset Management Central, Hong Kong $151M AUM 54.24% 1-Year Est. Return

Exane Derivatives's Q2 2021 Portfolio in Review

As of Q2 2021, Exane Derivatives held 1,099 positions worth $441M, up 26% from $350M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Exane Derivatives deployed $74.5M of net new capital in Q2 2021, opening 222 new positions and adding to 266 existing holdings. Its largest new stake was Alcon: 109,041 shares worth $7.62M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 11% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was iShares MSCI Taiwan ETF, an estimated $8.02M trimmed.

  • Exane Derivatives's largest Q2 2021 buy was Alcon: 109,041 shares worth $7.62M.
  • Exane Derivatives added most to UBS Group in Q2 2021, an estimated $15.4M increase.
  • Exane Derivatives's biggest Q2 2021 reduction was iShares MSCI Taiwan ETF, cutting an estimated $8.02M.
  • Exane Derivatives fully exited Deutsche Bank in Q2 2021, selling an estimated $4.27M.
  • Exane Derivatives's ten largest holdings make up 24% of its $441M portfolio in Q2 2021.
  • Exane Derivatives opened 222 new positions and closed 55 in Q2 2021.
  • Exane Derivatives's portfolio value rose 26% quarter-over-quarter to $441M.

Based on Exane Derivatives's 13F filing for Q2 2021, filed 28 Jul 2021.